美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

科爾黛倫礦業

14.67

+0.57004.04%

盤後：14.720.0500+0.34%19:59 EDT

成交量：1,772.87萬

成交額：2.58億

市值：94.29億

市盈率：37.80

高：14.75

開：14.31

低：14.27

收：14.10

52周最高：14.75

52周最低：4.58

股本：6.43億

流通股本：6.32億

量比：1.04

換手率：2.80%

股息：- -

股息率：- -

每股收益(TTM):0.3881

每股收益(LYR):0.1504

淨資產收益率：9.88%

總資產收益率：7.63%

市淨率：3.33

市盈率(LYR):97.56

資料載入中...

總覽公司新聞公告

諾誠健華大單品半年賣6.37億元：上了BTK抑制劑“牌桌”但未坐穩？

BUZZ-美元疲軟，白銀價格上漲，白銀礦工獲利

中國生物製藥公告宗艾替尼是勃林格殷格翰研發的一種共valsely結合、口服的選擇性HER2小分子抑制劑此前已被CDE授予

中國生物製藥(01177)：選擇性HER2 TKI“宗艾替尼”再次獲得CDE突破性治療資格認定

和譽-B(02256)：和譽醫藥的口服PD-L1抑制劑ABSK043與艾力斯的 KRAS G12C抑制劑枸櫞酸戈來雷塞片聯合用藥治療NSCLC的 IND申請獲CDE批准

智通财经网

榮昌生物：國家藥監局授予RC148突破性治療藥物認定用於治療非小細胞肺癌(NSCLC)

德琪醫藥-B：ATG-022就治療胃癌/胃食管結合部腺癌獲授予突破性治療藥物認定

德琪醫藥-B(06996.HK)：ATG-022就治療胃癌/胃食管結合部腺癌獲授予突破性治療藥物認定

海創藥業8000萬管線喊停的背後

CPHI制药在线

研報掘金｜中金：上調榮昌生物目標價至95.34港元維持“跑贏行業”評級

銀諾醫藥港交所上市|海思科 DPP-1抑制劑啓動Ⅲ期臨牀|復星小分子口服DPP-1抑制劑6.45億美元出海

中国医药创新促...

藥聞醫訊 | 關於公開徵求《罕見病用化學藥物藥學研究指導原則（徵求意見稿）》意見的通知

中慧生物CHO細胞新藥臨牀試驗獲中美當局批准

中慧生物-B(02627)：重組呼吸道合胞病毒疫苗(CHO細胞)(佐劑)的IND獲中國CDE及美國FDA批准

科濟藥業發佈2025中期業績

上半年利潤或不少於2400萬元，樂普生物的“盈虧平衡術”奏效了

Ofweek维科网

通化金馬：新藥在審評過程中出現暫停等情形正常狀態

以諾康啓動上市輔導；綠谷971再註冊申請未獲批准

21世纪经济报道

榮昌生物：泰它西普治療原發性乾燥綜合徵Ⅲ期臨牀研究達到主要研究終點

智通财经网

國內第2款！復宏漢霖和億勝生物"貝伐珠單抗"眼科製劑申報上市

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CDE/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDE\",,,,,undefined,":{"symbol":"CDE","market":"US","secType":"STK","nameCN":"科爾黛倫礦業","latestPrice":14.67,"timestamp":1757102400000,"preClose":14.1,"halted":0,"volume":17728674,"hourTrading":{"tag":"盘后","latestPrice":14.72,"preClose":14.67,"latestTime":"19:59 EDT","volume":366993,"amount":5384493.9902,"timestamp":1757116768462},"delay":0,"floatShares":632467592,"shares":642715694,"eps":0.388125,"marketStatus":"未開盤","change":0.57,"latestTime":"09-05 16:00:00 EDT","open":14.31,"high":14.75,"low":14.27,"amount":258484917.896352,"amplitude":0.034043,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.388125,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1757318400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":533797200000,"exchange":"NYSE","adjPreClose":14.1,"preHourTrading":{"tag":"盘前","latestPrice":14.22,"preClose":14.1,"latestTime":"09:29 EDT","volume":84387,"amount":1217502.72507,"timestamp":1757078999067},"postHourTrading":{"tag":"盘后","latestPrice":14.72,"preClose":14.67,"latestTime":"19:59 EDT","volume":366993,"amount":5384493.9902,"timestamp":1757116768462},"volumeRatio":1.0352995326557768,"impliedVol":0.6314,"impliedVolPercentile":0.196},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDE\",,,,,undefined,":{"symbol":"CDE","floatShares":632467592,"roa":"7.63%","roe":"9.88%","lyrEps":0.150366,"volumeRatio":1.0352995326557768,"shares":642715694,"dividePrice":0,"high":14.75,"amplitude":0.034043,"preClose":14.1,"low":14.27,"week52Low":4.58,"pbRate":"3.33","psRate":"6.46","week52High":14.75,"institutionHeld":0.7324,"latestPrice":14.67,"eps":0.388125,"divideRate":0,"volume":17728674,"delay":0,"ttmEps":0.388125,"open":14.31,"prevYearClose":5.72,"prevWeekClose":13.15,"prevMonthClose":13.15,"prevQuarterClose":8.86,"fiveDayClose":12.56,"twentyDayClose":11.28,"sixtyDayClose":9.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-06","symbol":"CDE","fiscalQuarterEnding":"2025/06","expectedEps":0.18,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":0.2},{"market":"US","date":"2025-05-07","symbol":"CDE","fiscalQuarterEnding":"2025/03","expectedEps":0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":0.11},{"date":"2025-02-19","symbol":"CDE","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":0.12,"defaultRemindTime":1739998800000,"name":null,"time":"盤後","dateTimestamp":1739941200000,"actualEps":null},{"market":"US","date":"2025-01-15","symbol":"CDE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1736917200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-11-06","symbol":"CDE","fiscalQuarterEnding":"2024/09","expectedEps":0.07,"name":null,"time":"盤後","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":0.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CDE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":9,"updateTime":1741665600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CDE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CDE","date":"2025-09-05","current":47.528669,"percent":0.840033,"low":-661.071469,"twenty":-37.711668,"median":-9.937221,"eighty":38.666785,"high":98.848269,"avg":-41.239758,"sd":141.434461,"marketCap":9062291285},"quantilePoints":[{"date":"2020-09-11","current":-6.257929,"twenty":-24.048991,"median":-5.205375,"eighty":-1.477956,"marketCap":1867034206},{"date":"2020-09-18","current":-6.633731,"twenty":-24.048991,"median":-5.262824,"eighty":-1.498624,"marketCap":1979153753},{"date":"2020-09-25","current":-5.857617,"twenty":-24.048991,"median":-5.340288,"eighty":-1.51873,"marketCap":1747602513},{"date":"2020-10-02","current":-6.078197,"twenty":-24.048991,"median":-5.437243,"eighty":-1.529196,"marketCap":1813411813},{"date":"2020-10-09","current":-6.699088,"twenty":-24.048991,"median":-5.503172,"eighty":-1.545952,"marketCap":1998652805},{"date":"2020-10-16","current":-6.478508,"twenty":-24.048991,"median":-5.57298,"eighty":-1.556417,"marketCap":1932843505},{"date":"2020-10-23","current":-6.380473,"twenty":-24.048991,"median":-5.747499,"eighty":-1.565136,"marketCap":1903594928},{"date":"2020-10-30","current":-6.699481,"twenty":-24.048991,"median":-5.79016,"eighty":-1.577937,"marketCap":1723200178},{"date":"2020-11-06","current":-8.424099,"twenty":-24.048991,"median":-5.836698,"eighty":-1.589845,"marketCap":2166796264},{"date":"2020-11-13","current":-7.722881,"twenty":-24.048991,"median":-5.867724,"eighty":-1.596943,"marketCap":1986433020},{"date":"2020-11-20","current":-7.211181,"twenty":-24.048991,"median":-5.887115,"eighty":-1.620053,"marketCap":1854816599},{"date":"2020-11-27","current":-6.765812,"twenty":-24.048991,"median":-5.914262,"eighty":-1.629011,"marketCap":1740261566},{"date":"2020-12-04","current":-7.60917,"twenty":-24.048991,"median":-5.94141,"eighty":-1.652492,"marketCap":1957184927},{"date":"2020-12-11","current":-8.092442,"twenty":-24.048991,"median":-6.003461,"eighty":-1.660764,"marketCap":2081489325},{"date":"2020-12-18","current":-9.220077,"twenty":-24.048991,"median":-6.074112,"eighty":-1.679713,"marketCap":2371532919},{"date":"2020-12-24","current":-9.362216,"twenty":-24.048991,"median":-6.241589,"eighty":-1.695563,"marketCap":2408093036},{"date":"2020-12-31","current":-9.807585,"twenty":-24.048991,"median":-6.262014,"eighty":-1.708496,"marketCap":2522648069},{"date":"2021-01-08","current":-9.087414,"twenty":-24.048991,"median":-6.368218,"eighty":-1.735169,"marketCap":2337410143},{"date":"2021-01-15","current":-7.950303,"twenty":-24.048991,"median":-6.433575,"eighty":-1.756573,"marketCap":2044929208},{"date":"2021-01-22","current":-8.149297,"twenty":-24.048991,"median":-6.475283,"eighty":-1.769383,"marketCap":2096113371},{"date":"2021-01-29","current":-8.575714,"twenty":-24.048991,"median":-6.494848,"eighty":-1.791801,"marketCap":2205793722},{"date":"2021-02-05","current":-8.945275,"twenty":-24.048991,"median":-6.633731,"eighty":-1.823826,"marketCap":2300850026},{"date":"2021-02-12","current":-8.623094,"twenty":-24.048991,"median":-6.699088,"eighty":-1.830231,"marketCap":2217980428},{"date":"2021-02-19","current":82.975518,"twenty":-24.048991,"median":-6.699284,"eighty":-1.832035,"marketCap":2126413608},{"date":"2021-02-26","current":85.636818,"twenty":-24.048991,"median":-6.699284,"eighty":-1.832035,"marketCap":2194614732},{"date":"2021-03-05","current":83.355704,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2136156626},{"date":"2021-03-12","current":90.389139,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2316402453},{"date":"2021-03-19","current":94.666227,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2426011402},{"date":"2021-03-26","current":87.537746,"twenty":-24.048991,"median":-6.699284,"eighty":-1.832035,"marketCap":2243329820},{"date":"2021-04-01","current":89.114576,"twenty":-24.048991,"median":-6.699284,"eighty":-1.832035,"marketCap":2283739238},{"date":"2021-04-09","current":90.349639,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2315390209},{"date":"2021-04-16","current":92.439747,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2368953389},{"date":"2021-04-23","current":91.489698,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2344606489},{"date":"2021-04-30","current":49.687188,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":1966966693},{"date":"2021-05-07","current":56.820497,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2249353001},{"date":"2021-05-14","current":57.126555,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2261468945},{"date":"2021-05-21","current":60.385659,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2390487087},{"date":"2021-05-28","current":63.952226,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2531676752},{"date":"2021-06-04","current":63.97379,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2532530416},{"date":"2021-06-11","current":69.689215,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2758786941},{"date":"2021-06-18","current":60.076909,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2378264604},{"date":"2021-06-25","current":57.608885,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2280562923},{"date":"2021-07-02","current":57.868677,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2290847311},{"date":"2021-07-09","current":55.400652,"twenty":-24.057064,"median":-6.699481,"eighty":-1.835716,"marketCap":2193145630},{"date":"2021-07-16","current":50.334708,"twenty":-24.057064,"median":-6.699481,"eighty":-1.829932,"marketCap":1992600074},{"date":"2021-07-23","current":47.606891,"twenty":-24.057064,"median":-6.699481,"eighty":-1.823826,"marketCap":1884614005},{"date":"2021-07-30","current":26.568703,"twenty":-24.057064,"median":-6.699481,"eighty":-1.802369,"marketCap":1937974366},{"date":"2021-08-06","current":24.524957,"twenty":-24.057064,"median":-6.699481,"eighty":-1.768998,"marketCap":1788899414},{"date":"2021-08-13","current":24.454483,"twenty":-24.048991,"median":-6.699284,"eighty":-1.754972,"marketCap":1783758899},{"date":"2021-08-20","current":21.846944,"twenty":-24.048991,"median":-6.699284,"eighty":-1.708496,"marketCap":1593559823},{"date":"2021-08-27","current":24.524957,"twenty":-24.048991,"median":-6.699284,"eighty":-1.693053,"marketCap":1788899414},{"date":"2021-09-03","current":25.687778,"twenty":-24.048991,"median":-6.699284,"eighty":-1.660764,"marketCap":1873717921},{"date":"2021-09-10","current":24.384009,"twenty":-24.048991,"median":-6.699284,"eighty":-1.656553,"marketCap":1778618383},{"date":"2021-09-17","current":21.952655,"twenty":-24.048991,"median":-6.699284,"eighty":-1.629011,"marketCap":1601270596},{"date":"2021-09-24","current":21.77647,"twenty":-24.048991,"median":-6.699284,"eighty":-1.601252,"marketCap":1588419308},{"date":"2021-10-01","current":21.952655,"twenty":-24.048991,"median":-6.699284,"eighty":-1.589845,"marketCap":1601270596},{"date":"2021-10-08","current":21.846944,"twenty":-24.047409,"median":-6.699088,"eighty":-1.5879,"marketCap":1593559823},{"date":"2021-10-15","current":22.410737,"twenty":-24.047409,"median":-6.699088,"eighty":-1.5879,"marketCap":1634683948},{"date":"2021-10-22","current":23.714506,"twenty":-24.047409,"median":-6.699088,"eighty":-1.582678,"marketCap":1729783485},{"date":"2021-10-29","current":-187.343691,"twenty":-24.218923,"median":-6.716929,"eighty":-1.57371,"marketCap":1626517921},{"date":"2021-11-05","current":-205.397348,"twenty":-24.374244,"median":-6.744021,"eighty":-1.57371,"marketCap":1783259774},{"date":"2021-11-12","current":-211.612541,"twenty":-24.788202,"median":-6.809378,"eighty":-1.583318,"marketCap":1837220084},{"date":"2021-11-19","current":-189.415422,"twenty":-24.857935,"median":-6.886989,"eighty":-1.648649,"marketCap":1644504691},{"date":"2021-11-26","current":-169.585995,"twenty":-24.944649,"median":-7.012186,"eighty":-1.683556,"marketCap":1472345606},{"date":"2021-12-03","current":-153.90003,"twenty":-25.143705,"median":-7.148417,"eighty":-1.750488,"marketCap":1336160061},{"date":"2021-12-10","current":-151.532337,"twenty":-25.448563,"median":-7.311809,"eighty":-1.801729,"marketCap":1315603752},{"date":"2021-12-17","current":-146.205029,"twenty":-27.281804,"median":-7.381747,"eighty":-1.82895,"marketCap":1269352058},{"date":"2021-12-23","current":-153.012145,"twenty":-27.894552,"median":-7.60917,"eighty":-1.850428,"marketCap":1328451445},{"date":"2021-12-31","current":-149.164645,"twenty":-75.296884,"median":-7.808164,"eighty":-1.872919,"marketCap":1295047444},{"date":"2022-01-07","current":-143.541374,"twenty":-76.925569,"median":-7.988207,"eighty":-1.908052,"marketCap":1246226211},{"date":"2022-01-14","current":-150.644453,"twenty":-77.700187,"median":-8.106656,"eighty":-2.233174,"marketCap":1307895137},{"date":"2022-01-21","current":-150.348491,"twenty":-78.256324,"median":-8.412477,"eighty":-2.305339,"marketCap":1305325598},{"date":"2022-01-28","current":-132.294834,"twenty":-78.872046,"median":-8.485591,"eighty":-2.474483,"marketCap":1148583745},{"date":"2022-02-04","current":-134.662526,"twenty":-79.150114,"median":-8.548547,"eighty":-2.679638,"marketCap":1169140053},{"date":"2022-02-11","current":-149.756568,"twenty":-79.745975,"median":-8.58519,"eighty":-2.7398,"marketCap":1300186521},{"date":"2022-02-18","current":-35.092989,"twenty":-79.76538,"median":-8.803025,"eighty":-2.896442,"marketCap":1099182593},{"date":"2022-02-25","current":-35.666939,"twenty":-79.76538,"median":-8.950013,"eighty":-2.962014,"marketCap":1117159879},{"date":"2022-03-04","current":-38.044735,"twenty":-79.76538,"median":-9.175403,"eighty":-3.004934,"marketCap":1191637204},{"date":"2022-03-11","current":-37.962742,"twenty":-79.76538,"median":-9.291146,"eighty":-3.069755,"marketCap":1189069020},{"date":"2022-03-18","current":-38.782672,"twenty":-79.76538,"median":-9.395382,"eighty":-3.167894,"marketCap":1214750856},{"date":"2022-03-25","current":-39.192637,"twenty":-79.76538,"median":-9.629822,"eighty":-3.296332,"marketCap":1227591775},{"date":"2022-04-01","current":-41.543478,"twenty":-79.76538,"median":-9.846853,"eighty":-3.344841,"marketCap":1301224810},{"date":"2022-04-08","current":-41.27603,"twenty":-79.76538,"median":-10.059489,"eighty":-3.458886,"marketCap":1292847826},{"date":"2022-04-14","current":-46.981572,"twenty":-79.76538,"median":-10.075381,"eighty":-3.519188,"marketCap":1471556813},{"date":"2022-04-22","current":-39.136452,"twenty":-79.76538,"median":-10.13593,"eighty":-3.637326,"marketCap":1225831956},{"date":"2022-04-29","current":-32.361121,"twenty":-79.76538,"median":-10.300251,"eighty":-3.681617,"marketCap":1013615034},{"date":"2022-05-06","current":-42.175583,"twenty":-79.76538,"median":-10.403526,"eighty":-3.681617,"marketCap":1083912491},{"date":"2022-05-13","current":-37.368004,"twenty":-79.76538,"median":-10.478374,"eighty":-3.681617,"marketCap":960357699},{"date":"2022-05-20","current":-40.099583,"twenty":-79.76538,"median":-10.548643,"eighty":-3.681617,"marketCap":1030559286},{"date":"2022-05-27","current":-44.360847,"twenty":-79.76538,"median":-10.672643,"eighty":-3.681617,"marketCap":1140073760},{"date":"2022-06-03","current":-45.562742,"twenty":-79.76538,"median":-10.79468,"eighty":-3.681617,"marketCap":1170962458},{"date":"2022-06-10","current":-44.251584,"twenty":-79.76538,"median":-10.92781,"eighty":-3.681617,"marketCap":1137265697},{"date":"2022-06-17","current":-37.368004,"twenty":-79.76538,"median":-11.156248,"eighty":-3.681617,"marketCap":960357699},{"date":"2022-06-24","current":-38.351372,"twenty":-79.784786,"median":-11.336454,"eighty":-3.67309,"marketCap":985630270},{"date":"2022-07-01","current":-33.543793,"twenty":-79.784786,"median":-11.421234,"eighty":-3.67309,"marketCap":862075479},{"date":"2022-07-08","current":-30.812214,"twenty":-79.784786,"median":-11.515804,"eighty":-3.67309,"marketCap":791873892},{"date":"2022-07-15","current":-30.047372,"twenty":-79.784786,"median":-11.648934,"eighty":-3.67309,"marketCap":772217448},{"date":"2022-07-22","current":-28.845477,"twenty":-79.784786,"median":-11.851748,"eighty":-3.67309,"marketCap":741328750},{"date":"2022-07-29","current":-35.073477,"twenty":-79.784786,"median":-12.891488,"eighty":-3.67309,"marketCap":901388367},{"date":"2022-08-05","current":-6.477723,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":876306387},{"date":"2022-08-12","current":-6.913724,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":935288548},{"date":"2022-08-19","current":-5.896389,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":797663506},{"date":"2022-08-26","current":-5.979437,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":808898204},{"date":"2022-09-02","current":-5.626484,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":761150740},{"date":"2022-09-09","current":-6.353152,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":859454341},{"date":"2022-09-16","current":-5.917151,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":800472181},{"date":"2022-09-23","current":-5.771817,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":780811460},{"date":"2022-09-30","current":-7.100581,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":960566617},{"date":"2022-10-07","current":-7.266677,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":983036012},{"date":"2022-10-14","current":-6.789152,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":918436502},{"date":"2022-10-21","current":-8.014106,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":1084148287},{"date":"2022-10-28","current":-7.95182,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":1075722264},{"date":"2022-11-04","current":-8.284011,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":1120661053},{"date":"2022-11-11","current":-7.127535,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":983286248},{"date":"2022-11-18","current":-6.618426,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":913051516},{"date":"2022-11-25","current":-6.923891,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":955192355},{"date":"2022-12-02","current":-7.086806,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":977667469},{"date":"2022-12-09","current":-6.781341,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":935526630},{"date":"2022-12-16","current":-7.009176,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":966957845},{"date":"2022-12-23","current":-7.352132,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":1014270767},{"date":"2022-12-30","current":-7.202089,"twenty":-79.784786,"median":-13.172187,"eighty":-3.67309,"marketCap":993571363},{"date":"2023-01-06","current":-7.888002,"twenty":-79.229562,"median":-12.248023,"eighty":-3.67309,"marketCap":1088197207},{"date":"2023-01-13","current":-8.145219,"twenty":-78.991218,"median":-11.7155,"eighty":-3.67309,"marketCap":1123681899},{"date":"2023-01-20","current":-8.938307,"twenty":-78.673426,"median":-11.648934,"eighty":-3.67309,"marketCap":1233093031},{"date":"2023-01-27","current":-8.488176,"twenty":-78.196738,"median":-11.503106,"eighty":-3.67309,"marketCap":1170994821},{"date":"2023-02-03","current":-7.802263,"twenty":-77.302947,"median":-11.382673,"eighty":-3.67309,"marketCap":1076368977},{"date":"2023-02-10","current":-7.395002,"twenty":-75.992054,"median":-11.239837,"eighty":-3.67309,"marketCap":1020184882},{"date":"2023-02-17","current":-7.094915,"twenty":-74.601714,"median":-11.052807,"eighty":-3.67309,"marketCap":978786075},{"date":"2023-02-24","current":-11.128267,"twenty":-46.720295,"median":-11.00547,"eighty":-3.67309,"marketCap":869195520},{"date":"2023-03-03","current":-12.074548,"twenty":-44.821298,"median":-11.00547,"eighty":-3.67309,"marketCap":943106704},{"date":"2023-03-10","current":-10.787605,"twenty":-43.971179,"median":-10.901159,"eighty":-3.67309,"marketCap":842587494},{"date":"2023-03-17","current":-11.658184,"twenty":-42.372257,"median":-10.901159,"eighty":-3.67309,"marketCap":910585783},{"date":"2023-03-24","current":-12.490912,"twenty":-41.757436,"median":-10.901159,"eighty":-3.67309,"marketCap":975627625},{"date":"2023-03-31","current":-17.063788,"twenty":-41.133392,"median":-10.920084,"eighty":-3.681617,"marketCap":1332801309},{"date":"2023-04-06","current":-18.047415,"twenty":-40.121436,"median":-10.920084,"eighty":-3.681617,"marketCap":1409629455},{"date":"2023-04-14","current":-18.945509,"twenty":-39.671347,"median":-10.901159,"eighty":-3.67309,"marketCap":1479776892},{"date":"2023-04-21","current":-16.122928,"twenty":-39.158926,"median":-10.901159,"eighty":-3.67309,"marketCap":1259313518},{"date":"2023-04-28","current":-14.925469,"twenty":-38.720566,"median":-10.901159,"eighty":-3.67309,"marketCap":1165783601},{"date":"2023-05-05","current":-15.438666,"twenty":-38.285814,"median":-10.901159,"eighty":-3.67309,"marketCap":1205867851},{"date":"2023-05-12","current":-10.317426,"twenty":-37.913547,"median":-10.85015,"eighty":-3.67309,"marketCap":1138785842},{"date":"2023-05-19","current":-9.655391,"twenty":-37.368004,"median":-10.783585,"eighty":-3.67309,"marketCap":1065713814},{"date":"2023-05-26","current":-8.991583,"twenty":-36.929631,"median":-10.628266,"eighty":-3.67309,"marketCap":992445989},{"date":"2023-06-01","current":-9.051929,"twenty":-36.646867,"median":-10.587358,"eighty":-3.67309,"marketCap":999106701},{"date":"2023-06-09","current":-9.685564,"twenty":-35.666939,"median":-10.499327,"eighty":-3.664562,"marketCap":1069044170},{"date":"2023-06-16","current":-9.383833,"twenty":-35.34355,"median":-10.414044,"eighty":-3.664562,"marketCap":1035740613},{"date":"2023-06-23","current":-8.689852,"twenty":-34.962589,"median":-10.362005,"eighty":-3.656035,"marketCap":959142432},{"date":"2023-06-30","current":-8.861789,"twenty":-33.871582,"median":-10.23408,"eighty":-3.646043,"marketCap":978120000},{"date":"2023-07-07","current":-8.242084,"twenty":-33.223325,"median":-10.138161,"eighty":-3.646043,"marketCap":909720000},{"date":"2023-07-14","current":-9.51248,"twenty":-32.21271,"median":-10.080427,"eighty":-3.643112,"marketCap":1049940000},{"date":"2023-07-21","current":-9.729377,"twenty":-30.94333,"median":-10.070215,"eighty":-3.643112,"marketCap":1073880000},{"date":"2023-07-28","current":-9.047701,"twenty":-30.397014,"median":-10.008245,"eighty":-3.643112,"marketCap":998640000},{"date":"2023-08-04","current":-8.39701,"twenty":-29.959961,"median":-9.892868,"eighty":-3.643112,"marketCap":926820000},{"date":"2023-08-11","current":-12.807338,"twenty":-27.653249,"median":-9.83643,"eighty":-3.643112,"marketCap":836997980},{"date":"2023-08-18","current":-13.509851,"twenty":-26.474315,"median":-9.83643,"eighty":-3.643112,"marketCap":882909262},{"date":"2023-08-25","current":-13.726008,"twenty":-25.346238,"median":-9.83643,"eighty":-3.643112,"marketCap":897035810},{"date":"2023-09-01","current":-13.023496,"twenty":-25.014893,"median":-9.83643,"eighty":-3.643112,"marketCap":851124529},{"date":"2023-09-08","current":-12.158865,"twenty":-24.901468,"median":-9.83643,"eighty":-3.643112,"marketCap":794618336},{"date":"2023-09-15","current":-12.375023,"twenty":-24.830358,"median":-9.83643,"eighty":-3.643112,"marketCap":808744884},{"date":"2023-09-22","current":-12.268931,"twenty":-24.435791,"median":-9.83643,"eighty":-3.641646,"marketCap":801811426},{"date":"2023-09-29","current":-12.731909,"twenty":-24.295395,"median":-9.83643,"eighty":-3.640181,"marketCap":832068461},{"date":"2023-10-06","current":-12.211058,"twenty":-24.065138,"median":-9.807585,"eighty":-3.634471,"marketCap":798029297},{"date":"2023-10-13","current":-12.963398,"twenty":-23.92384,"median":-9.807585,"eighty":-3.634471,"marketCap":847196978},{"date":"2023-10-19","current":-15.394036,"twenty":-23.828594,"median":-9.776084,"eighty":-3.628761,"marketCap":1006046412},{"date":"2023-10-27","current":-14.294462,"twenty":-23.50993,"median":-9.745911,"eighty":-3.608775,"marketCap":934185954},{"date":"2023-11-03","current":-13.947228,"twenty":-23.368005,"median":-9.745911,"eighty":-3.608775,"marketCap":911493178},{"date":"2023-11-10","current":-28.875704,"twenty":-23.20653,"median":-9.745911,"eighty":-3.608775,"marketCap":837915192},{"date":"2023-11-17","current":-32.699428,"twenty":-23.469183,"median":-9.745911,"eighty":-3.608775,"marketCap":948871998},{"date":"2023-11-24","current":-37.577972,"twenty":-23.737257,"median":-9.745911,"eighty":-3.608775,"marketCap":1090437579},{"date":"2023-12-01","current":-40.215022,"twenty":-23.978559,"median":-9.745911,"eighty":-3.608775,"marketCap":1166959514},{"date":"2023-12-08","current":-40.478727,"twenty":-24.238636,"median":-9.754612,"eighty":-3.614486,"marketCap":1174611708},{"date":"2023-12-15","current":-46.412091,"twenty":-24.398777,"median":-9.754612,"eighty":-3.614486,"marketCap":1346786063},{"date":"2023-12-22","current":-46.675796,"twenty":-24.800789,"median":-9.754612,"eighty":-3.614486,"marketCap":1354438256},{"date":"2023-12-29","current":-43.775041,"twenty":-24.837483,"median":-9.745911,"eighty":-3.608775,"marketCap":1270264127},{"date":"2024-01-05","current":-38.369087,"twenty":-24.926558,"median":-9.744377,"eighty":-3.603065,"marketCap":1113394160},{"date":"2024-01-12","current":-35.072773,"twenty":-25.055699,"median":-9.744377,"eighty":-3.603065,"marketCap":1017741740},{"date":"2024-01-19","current":-34.545363,"twenty":-25.428851,"median":-9.742844,"eighty":-3.597355,"marketCap":1002437353},{"date":"2024-01-26","current":-36.523151,"twenty":-26.84661,"median":-9.744377,"eighty":-3.603065,"marketCap":1059828805},{"date":"2024-02-02","current":-37.709824,"twenty":-27.806661,"median":-9.744377,"eighty":-3.603065,"marketCap":1094263676},{"date":"2024-02-09","current":-35.336479,"twenty":-29.638217,"median":-9.744377,"eighty":-3.603065,"marketCap":1025393934},{"date":"2024-02-16","current":-35.995741,"twenty":-30.244045,"median":-9.744377,"eighty":-3.603065,"marketCap":1044524418},{"date":"2024-02-23","current":-9.916927,"twenty":-30.452756,"median":-9.742048,"eighty":-3.603065,"marketCap":1027512665},{"date":"2024-03-01","current":-9.65549,"twenty":-30.421087,"median":-9.685564,"eighty":-3.608775,"marketCap":1000424599},{"date":"2024-03-08","current":-11.892283,"twenty":-30.421087,"median":-9.685564,"eighty":-3.608775,"marketCap":1232183193},{"date":"2024-03-15","current":-11.817723,"twenty":-30.421087,"median":-9.685564,"eighty":-3.608775,"marketCap":1224457907},{"date":"2024-03-22","current":-12.67516,"twenty":-30.421087,"median":-9.685564,"eighty":-3.608775,"marketCap":1313298701},{"date":"2024-03-28","current":-13.574388,"twenty":-30.421087,"median":-9.685564,"eighty":-3.608775,"marketCap":1406469504},{"date":"2024-04-05","current":-16.699001,"twenty":-30.452756,"median":-9.685564,"eighty":-3.603065,"marketCap":1730216863},{"date":"2024-04-12","current":-18.426573,"twenty":-30.452756,"median":-9.685564,"eighty":-3.603065,"marketCap":1909214107},{"date":"2024-04-19","current":-17.080164,"twenty":-30.452756,"median":-9.685564,"eighty":-3.603065,"marketCap":1769709945},{"date":"2024-04-26","current":-18.54198,"twenty":-30.421087,"median":-9.685564,"eighty":-3.608775,"marketCap":1921171607},{"date":"2024-05-03","current":-17.687186,"twenty":-30.421087,"median":-9.729377,"eighty":-3.608775,"marketCap":1912745343},{"date":"2024-05-10","current":-20.271952,"twenty":-30.421087,"median":-9.729377,"eighty":-3.608775,"marketCap":2192269715},{"date":"2024-05-17","current":-19.459597,"twenty":-30.421087,"median":-9.763313,"eighty":-3.608775,"marketCap":2104419198},{"date":"2024-05-24","current":-19.828849,"twenty":-30.421087,"median":-9.886122,"eighty":-3.608775,"marketCap":2144351251},{"date":"2024-05-31","current":-21.564335,"twenty":-30.421087,"median":-9.957515,"eighty":-3.608775,"marketCap":2332031901},{"date":"2024-06-07","current":-21.822812,"twenty":-30.421087,"median":-10.008245,"eighty":-3.608775,"marketCap":2359984338},{"date":"2024-06-14","current":-19.791924,"twenty":-30.452756,"median":-10.008245,"eighty":-3.603065,"marketCap":2140358046},{"date":"2024-06-21","current":-21.675111,"twenty":-30.484424,"median":-10.008245,"eighty":-3.597355,"marketCap":2344011516},{"date":"2024-06-28","current":-20.641204,"twenty":-30.547642,"median":-9.972405,"eighty":-3.584507,"marketCap":2232201768},{"date":"2024-07-05","current":-22.007438,"twenty":-30.547642,"median":-9.972405,"eighty":-3.584507,"marketCap":2379950364},{"date":"2024-07-12","current":-24.998382,"twenty":-30.547642,"median":-9.972405,"eighty":-3.584507,"marketCap":2703399994},{"date":"2024-07-15","current":-24.592204,"twenty":-30.547642,"median":-9.972405,"eighty":-3.584507,"marketCap":2659474736},{"date":"2024-08-02","current":-22.155139,"twenty":-30.593687,"median":-9.807585,"eighty":-3.519188,"marketCap":2395923186},{"date":"2024-08-09","current":-28.907186,"twenty":-30.593687,"median":-9.807585,"eighty":-3.519188,"marketCap":2147948461},{"date":"2024-08-16","current":-31.701189,"twenty":-30.84684,"median":-9.807585,"eighty":-3.519188,"marketCap":2355556863},{"date":"2024-08-23","current":-33.904153,"twenty":-31.689293,"median":-9.807585,"eighty":-3.519188,"marketCap":2519248103},{"date":"2024-08-30","current":-33.205652,"twenty":-32.361121,"median":-9.807585,"eighty":-3.519188,"marketCap":2467346002},{"date":"2024-09-06","current":-29.498225,"twenty":-32.422566,"median":-9.807585,"eighty":-3.519188,"marketCap":2191865623},{"date":"2024-09-13","current":-36.805618,"twenty":-32.668344,"median":-9.83643,"eighty":-3.519188,"marketCap":2734841443},{"date":"2024-09-20","current":-37.128003,"twenty":-33.207722,"median":-9.892868,"eighty":-3.519188,"marketCap":2758796258},{"date":"2024-09-27","current":-40.351853,"twenty":-33.585884,"median":-9.892868,"eighty":-3.519188,"marketCap":2998344414},{"date":"2024-10-04","current":-38.041427,"twenty":-33.878096,"median":-9.892868,"eighty":-3.519188,"marketCap":2826668236},{"date":"2024-10-11","current":-34.391226,"twenty":-34.086838,"median":-9.892868,"eighty":-3.519188,"marketCap":2555440038},{"date":"2024-10-18","current":-34.821116,"twenty":-34.347538,"median":-9.916927,"eighty":-3.519188,"marketCap":2587383038},{"date":"2024-10-25","current":-38.206502,"twenty":-34.459777,"median":-9.916927,"eighty":-3.519188,"marketCap":2838934167},{"date":"2024-10-31","current":-36.64815,"twenty":-34.577391,"median":-9.916927,"eighty":-3.519188,"marketCap":2723140790},{"date":"2024-11-08","current":-590.306366,"twenty":-34.734776,"median":-9.904898,"eighty":-3.519102,"marketCap":2630995474},{"date":"2024-11-15","current":-558.058978,"twenty":-35.080005,"median":-9.904898,"eighty":-3.519102,"marketCap":2487268863},{"date":"2024-11-22","current":-593.889409,"twenty":-35.204626,"median":-9.904898,"eighty":-3.519102,"marketCap":2646965098},{"date":"2024-11-29","current":-578.661476,"twenty":-35.343842,"median":-9.904898,"eighty":-3.519102,"marketCap":2579094198},{"date":"2024-12-06","current":-609.117343,"twenty":-35.505984,"median":-9.904898,"eighty":-3.519102,"marketCap":2714835998},{"date":"2024-12-13","current":-617.17919,"twenty":-35.692978,"median":-9.904898,"eighty":-3.519102,"marketCap":2750767651},{"date":"2024-12-20","current":-516.853981,"twenty":-36.048482,"median":-9.904898,"eighty":-3.519102,"marketCap":2303618192},{"date":"2024-12-27","current":-528.498871,"twenty":-36.31484,"median":-9.904898,"eighty":-3.519102,"marketCap":2355519469},{"date":"2025-01-03","current":-555.371695,"twenty":-36.544858,"median":-9.904898,"eighty":-3.519102,"marketCap":2475291645},{"date":"2025-01-10","current":-576.869954,"twenty":-36.655004,"median":-9.892868,"eighty":-3.519015,"marketCap":2571109386},{"date":"2025-01-17","current":-554.475934,"twenty":-36.798113,"median":-9.892868,"eighty":-3.519015,"marketCap":2471299239},{"date":"2025-01-24","current":-560.74626,"twenty":-37.015659,"median":-9.892868,"eighty":-3.519015,"marketCap":2499246080},{"date":"2025-01-31","current":-613.596147,"twenty":-37.239761,"median":-9.892868,"eighty":-3.519015,"marketCap":2734798027},{"date":"2025-02-07","current":-622.553755,"twenty":-37.417434,"median":-9.892868,"eighty":-3.519015,"marketCap":2774722086},{"date":"2025-02-14","current":-646.859762,"twenty":-37.577972,"median":-9.892868,"eighty":-3.519015,"marketCap":2883053960},{"date":"2025-02-21","current":66.132479,"twenty":-37.704212,"median":-9.892868,"eighty":-3.486008,"marketCap":3895203037},{"date":"2025-02-28","current":54.423778,"twenty":-37.704212,"median":-9.892868,"eighty":-3.443183,"marketCap":3205560532},{"date":"2025-03-07","current":59.627645,"twenty":-37.707018,"median":-9.904898,"eighty":-3.45032,"marketCap":3512068312},{"date":"2025-03-14","current":64.40682,"twenty":-37.707018,"median":-9.904898,"eighty":-3.45032,"marketCap":3793561706},{"date":"2025-03-21","current":69.611412,"twenty":-37.707018,"median":-9.904898,"eighty":-3.45032,"marketCap":4100112147},{"date":"2025-03-28","current":68.74398,"twenty":-37.707018,"median":-9.904898,"eighty":-3.45032,"marketCap":4049020407},{"date":"2025-04-04","current":59.527516,"twenty":-37.707018,"median":-9.904898,"eighty":-3.45032,"marketCap":3506170668},{"date":"2025-04-11","current":59.606864,"twenty":-37.704212,"median":-9.892868,"eighty":-3.443183,"marketCap":3510844278},{"date":"2025-04-17","current":68.075599,"twenty":-37.704212,"median":-9.892868,"eighty":-3.443183,"marketCap":4009652754},{"date":"2025-04-25","current":63.406937,"twenty":-37.707018,"median":-9.904898,"eighty":-3.45032,"marketCap":3734668594},{"date":"2025-05-02","current":58.629702,"twenty":-37.707018,"median":-9.904898,"eighty":-3.45032,"marketCap":3453289453},{"date":"2025-05-09","current":36.736351,"twenty":-37.707018,"median":-9.904898,"eighty":-3.45032,"marketCap":4458690884},{"date":"2025-05-16","current":39.055432,"twenty":-37.707018,"median":-9.904898,"eighty":-3.441755,"marketCap":4740157741},{"date":"2025-05-23","current":40.68933,"twenty":-37.707018,"median":-9.904898,"eighty":-3.306141,"marketCap":4938463935},{"date":"2025-05-30","current":42.902998,"twenty":-37.707018,"median":-9.904898,"eighty":21.367721,"marketCap":5207136844},{"date":"2025-06-06","current":49.860241,"twenty":-37.707018,"median":-9.904898,"eighty":21.734186,"marketCap":6051537413},{"date":"2025-06-13","current":48.542581,"twenty":-37.707018,"median":-9.904898,"eighty":21.839897,"marketCap":5891613063},{"date":"2025-06-20","current":47.54116,"twenty":-37.709824,"median":-9.916927,"eighty":21.952655,"marketCap":5770070557},{"date":"2025-06-27","current":47.699279,"twenty":-37.709824,"median":-9.916927,"eighty":22.093604,"marketCap":5789261479},{"date":"2025-07-03","current":48.068224,"twenty":-37.709824,"median":-9.916927,"eighty":22.445974,"marketCap":5834040297},{"date":"2025-07-11","current":48.015517,"twenty":-37.709824,"median":-9.916927,"eighty":23.08024,"marketCap":5827643323},{"date":"2025-07-18","current":48.384462,"twenty":-37.709824,"median":-9.916927,"eighty":23.644032,"marketCap":5872422141},{"date":"2025-07-25","current":49.544002,"twenty":-37.709824,"median":-9.916927,"eighty":24.13735,"marketCap":6013155569},{"date":"2025-08-01","current":45.801849,"twenty":-37.709824,"median":-9.916927,"eighty":24.454483,"marketCap":5558970414},{"date":"2025-08-08","current":38.022935,"twenty":-37.709824,"median":-9.916927,"eighty":24.630668,"marketCap":7249833028},{"date":"2025-08-15","current":39.067892,"twenty":-37.709824,"median":-9.916927,"eighty":24.912564,"marketCap":7449074893},{"date":"2025-08-22","current":39.337558,"twenty":-37.709824,"median":-9.916927,"eighty":25.723015,"marketCap":7500492148},{"date":"2025-08-29","current":42.337594,"twenty":-37.709824,"median":-9.916927,"eighty":33.337485,"marketCap":8072509116},{"date":"2025-09-05","current":47.528669,"twenty":-37.711668,"median":-9.937221,"eighty":38.666785,"marketCap":9062291285}],"updateTime":1757290385016},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDE\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561410554","title":"諾誠健華大單品半年賣6.37億元：上了BTK抑制劑“牌桌”但未坐穩？","url":"https://stock-news.laohu8.com/highlight/detail?id=2561410554","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561410554?lang=zh_tw&edition=fundamental","pubTime":"2025-08-21 08:56","pubTimestamp":1755737769,"startTime":"0","endTime":"0","summary":"靠奥布替尼走上BTK抑制剂“牌桌”肿瘤治疗需求驱动下，BTK抑制剂赛道的温度一直不低。对比大型跨国药企，诺诚健华显然不太占据规模和声量优势，但能走上BTK抑制剂的“牌桌”，也证明其拥有独特身位。作为诺诚健华首个上市产品，奥布替尼可以说是BTK抑制剂领域比较成功的突围范本。仅以当前的成绩来看，诺诚健华的奥布替尼“上了牌桌”，似乎难以“稳坐牌桌”。财报显示，截至2025年6月30日，诺诚健华持有现金及相关账户结余约76.8亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250821090201a494f113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250821090201a494f113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1674673691.USD","CDE","IE00BVYPNV92.GBP","LU0203345920.USD","LU1778281490.HKD","IE00BGHQF631.EUR","SG9999002232.USD","BK4527","LU1196500208.SGD","LU1223082519.USD","SG9999015978.USD","BK4585","IE00B3PB1722.GBP","LU0234570918.USD","LU2417539215.USD","IE00B3T34201.USD","LU0868494617.USD","LU1599440770.SGD","IE000M9KFDE8.USD","LU0234572021.USD","LU1430594728.SGD","LU1267930813.SGD","LU0731783394.SGD","LU1880398471.USD","BK4560","BK4588","IE00BZ1G4Q59.USD","SG9999015952.SGD","LU1223083913.SGD","BK4534","BK4533","LU1066051498.USD","LU1244550221.USD","LU1880398554.USD","LU1046421795.USD","IE00BKVL7J92.USD","LU0348723411.USD","IE00B42XCP33.USD","IE00BFXG1179.USD","CSCO","LU1894683348.USD","SG9999015945.SGD","LU1223082196.USD","LU2506952170.USD","LU1066051225.USD","LU1221951046.USD","LU1221951129.SGD","BK4525","LU2506951875.HKD","LU2237443465.HKD"],"gpt_icon":0},{"id":"2560104962","title":"BUZZ-美元疲軟，白銀價格上漲，白銀礦工獲利","url":"https://stock-news.laohu8.com/highlight/detail?id=2560104962","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560104962?lang=zh_tw&edition=fundamental","pubTime":"2025-08-20 22:16","pubTimestamp":1755699411,"startTime":"0","endTime":"0","summary":"** 赫克拉矿业公司HL.N上涨1.1%，Coeur矿业公司CDE.N小幅上涨** 加拿大矿商Endeavour Silver EDR.TO上涨1.2%，Silvercorp Metals SVM.TO上涨1.5** Abrdn 实物白银 ETF SIVR.P 和 iShares Silver Trust SLV.P 分别上涨 1(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nL4S3UC12B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0345780521.USD","BK4570","SIVR","LU1223083913.SGD","LU1223082196.USD","LU1223082519.USD","HL","SLV","BK4547","BK4588","LU0345780281.USD","BK4210","CDE","BK4017"],"gpt_icon":0},{"id":"2560105032","title":"中國生物製藥公告宗艾替尼是勃林格殷格翰研發的一種共valsely結合、口服的選擇性HER2小分子抑制劑此前已被CDE授予","url":"https://stock-news.laohu8.com/highlight/detail?id=2560105032","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560105032?lang=zh_tw&edition=fundamental","pubTime":"2025-08-20 20:41","pubTimestamp":1755693695,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ08YR35.GBP","BK1191","LU1223082196.USD","BK1589","BK4017","BK1521","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","01177","CDE","LU1223083913.SGD","LU1223082519.USD","BK1515"],"gpt_icon":0},{"id":"2560106811","title":"中國生物製藥(01177)：選擇性HER2 TKI“宗艾替尼”再次獲得CDE突破性治療資格認定","url":"https://stock-news.laohu8.com/highlight/detail?id=2560106811","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560106811?lang=zh_tw&edition=fundamental","pubTime":"2025-08-20 20:41","pubTimestamp":1755693680,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，选择性 HER2酪氨酸激酶抑制剂“宗艾替尼”再次获得中国国家药品监督管理局药品审评中心突破性治疗资格认定，用于治疗携带HER2酪氨酸激酶结构域激活突变的不可切除或转移性非小细胞肺癌成人患者的一线治疗。此次突破性治疗资格认定是基于其Beamion LUNG-1临床试验数据。此前，宗艾替尼已被CDE授予用于HER2突变晚期非小细胞肺癌经治患者适应症优先审评和突破性治疗资格认定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1332382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1223083913.SGD","BK1191","BK1589","01177","IE00BZ08YR35.GBP","BK1521","BK4017","CDE","BK1515","LU1223082519.USD","IE00BZ08YS42.EUR","LU1223082196.USD","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2560170789","title":"和譽-B(02256)：和譽醫藥的口服PD-L1抑制劑ABSK043與艾力斯的 KRAS G12C抑制劑枸櫞酸戈來雷塞片聯合用藥治療NSCLC的 IND申請獲CDE批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2560170789","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560170789?lang=zh_tw&edition=fundamental","pubTime":"2025-08-20 19:27","pubTimestamp":1755689260,"startTime":"0","endTime":"0","summary":"和誉-B(02256)公布，公司附属公司和誉医药在研的口服PD-L1抑制剂ABSK...","market":"fut","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_1.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_1.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1332316.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","LU1169590202.USD","02256","BK1515","688578","BK1161","LU1223082519.USD","LU2488822045.USD","PD","09939","159938","LU1169589451.USD","LU1223082196.USD","LU1223083913.SGD","BK4017","BK0239","BK4023","CDE"],"gpt_icon":0},{"id":"2560143840","title":"榮昌生物：國家藥監局授予RC148突破性治療藥物認定用於治療非小細胞肺癌(NSCLC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2560143840","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560143840?lang=zh_tw&edition=fundamental","pubTime":"2025-08-19 17:28","pubTimestamp":1755595680,"startTime":"0","endTime":"0","summary":"格隆汇8月19日丨荣昌生物发布公告，公司原研的新型双特异性抗体RC148被中国国家药品监督管理局药品审评中心正式纳入突破性治疗药物品种，针对适应症为：RC148联合多西他赛治疗经PD-1/PD-L1抑制剂和含铂化疗治疗失败的驱动基因阴性局部晚期或转移性非小细胞肺癌。对纳入突破性治疗药物的创新药，CDE将优先配置资源，新药上市时间将大大缩短。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819172958a6eed188&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819172958a6eed188&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4017","LU1223083913.SGD","LU1223082196.USD","CDE","LU1223082519.USD","ORR"],"gpt_icon":0},{"id":"2560191312","title":"德琪醫藥-B：ATG-022就治療胃癌/胃食管結合部腺癌獲授予突破性治療藥物認定","url":"https://stock-news.laohu8.com/highlight/detail?id=2560191312","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560191312?lang=zh_tw&edition=fundamental","pubTime":"2025-08-19 12:29","pubTimestamp":1755577777,"startTime":"0","endTime":"0","summary":"德琪医药-B(06996)发布公告，公司董事会欣然宣布，公司内部研发的Claudi...德琪医药-B(06996)发布公告，公司董事会欣然宣布，公司内部研发的Claudin 18.2抗体药物偶联物 (ADC) ATG-022就治疗既往接受过至少两种治疗的CLDN18.2阳性、HER2阴性不可切除或转移性胃癌或胃食管结合部腺癌(GC/GEJ)患者获中国国家药品监督管理局(NMPA)药品审评中心(CDE)授予突破性治疗药物认定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819123812a6ee4b92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819123812a6ee4b92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4080","BK4017","LU1223082519.USD","LU1223082196.USD","ADC","BK4231","LU1223083913.SGD","CDE"],"gpt_icon":0},{"id":"2560151287","title":"德琪醫藥-B(06996.HK)：ATG-022就治療胃癌/胃食管結合部腺癌獲授予突破性治療藥物認定","url":"https://stock-news.laohu8.com/highlight/detail?id=2560151287","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560151287?lang=zh_tw&edition=fundamental","pubTime":"2025-08-19 12:23","pubTimestamp":1755577393,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4017","BK1583","ADC.AU","BK1191","ADC","LU1223083913.SGD","06996","LU1223082196.USD","BK4080","CDE","BK7095","BK4231","BK1574","LU1223082519.USD","CDE.AU","BK7050"],"gpt_icon":0},{"id":"2560189851","title":"海創藥業8000萬管線喊停的背後","url":"https://stock-news.laohu8.com/highlight/detail?id=2560189851","media":"CPHI制药在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560189851?lang=zh_tw&edition=fundamental","pubTime":"2025-08-18 17:01","pubTimestamp":1755507715,"startTime":"0","endTime":"0","summary":"近日，海创药业宣布暂停投入超8000万的HP501管线研发，这并非失败者的退场，而是清醒者的战略转身。面对如此激烈的竞争格局，海创药业的 HP501 即便成功上市，在市场份额争夺上也面临巨大挑战。如恒瑞医药SHR4640 在 URAT1 抑制剂研发上的快速进展，促使海创药业重新审视 HP501 项目的前景。海创药业暂停 HP501 项目，为行业提供了一个极具价值的样本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818170934a48f4c33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818170934a48f4c33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDE","LU1223082519.USD","LU1223082196.USD","BK4017","LU1223083913.SGD"],"gpt_icon":0},{"id":"2560597142","title":"研報掘金｜中金：上調榮昌生物目標價至95.34港元 維持“跑贏行業”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2560597142","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560597142?lang=zh_tw&edition=fundamental","pubTime":"2025-08-18 14:05","pubTimestamp":1755497132,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1064131003.USD","CDE","BK7050","BK1161","III","LU1223082519.USD","LU2148510915.USD","LU1969619763.USD","06978","CDE.AU","159992","BK1583","LU2328871848.SGD","LU1223082196.USD","09995","BK4134","LU2488822045.USD","LU1064130708.USD","LU1223083913.SGD","BK0239","BK4017","BK1574","688331"],"gpt_icon":0},{"id":"2560908719","title":"銀諾醫藥港交所上市|海思科 DPP-1抑制劑啓動Ⅲ期臨牀|復星小分子口服DPP-1抑制劑6.45億美元出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2560908719","media":"中国医药创新促...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560908719?lang=zh_tw&edition=fundamental","pubTime":"2025-08-18 13:39","pubTimestamp":1755495548,"startTime":"0","endTime":"0","summary":"新药审批正大天晴 TQB3142 TQB31228月12日，正大天晴宣布，其2款1类新药的临床试验申请获国家药品监督管理局受理，分别为Bcl-xL PROTAC药物TQB3142、高选择性PARP1抑制剂TQB3122。2款新药拟用于治疗恶性肿瘤，目前全球范围内均未有同类产品上市。8月11日，复星医药宣布其子公司复星医药产业与Expedition Therapeutics签订《许可协议》，将向Expedition授予小分子口服二肽基肽酶1抑制剂XH-S004在全球范围的开发、生产及商业化权利。8月15日，银诺医药正式在香港联合交易所主板挂牌上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818134122a48ee786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818134122a48ee786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDE","ITP","LU1223083913.SGD","BK4199","LU1223082519.USD","BK4017","LU1223082196.USD"],"gpt_icon":0},{"id":"2560971514","title":"藥聞醫訊 | 關於公開徵求《罕見病用化學藥物藥學研究指導原則（徵求意見稿）》意見的通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2560971514","media":"百诚医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560971514?lang=zh_tw&edition=fundamental","pubTime":"2025-08-18 11:02","pubTimestamp":1755486133,"startTime":"0","endTime":"0","summary":"政策简报关于公开征求《罕见病用化学药物药学研究指导原则》意见的通知罕见病具有发病率/患病率低的重要特征，由于中国人口基数庞大，罕见病患者的绝对数量并不少，存在未被满足的临床需求，是重要的公共健康问题之一。为提高罕见病药物研发效率，鼓励和加速推动罕见病药物研发上市，国家药品监督管理局药品审评中心组织起草了《罕见病用化学药物药学研究指导原则》，并于8月14日发布，向社会各界征求意见。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818122513a6ec28be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818122513a6ec28be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1223082519.USD","LU1223083913.SGD","BK4017","BK4097","BK4199","CDE","BK4023","ITP","LU1223082196.USD","ANY"],"gpt_icon":0},{"id":"2560273279","title":"中慧生物CHO細胞新藥臨牀試驗獲中美當局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2560273279","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560273279?lang=zh_tw&edition=fundamental","pubTime":"2025-08-17 22:20","pubTimestamp":1755440409,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4017","IND.AU","BK4505","RNA","LU1223083913.SGD","LU1223082196.USD","BK4139","BK4585","159646","BK4588","BK7095","CDE","CDE.AU","LU1223082519.USD","BK7050"],"gpt_icon":0},{"id":"2560922523","title":"中慧生物-B(02627)：重組呼吸道合胞病毒疫苗(CHO細胞)(佐劑)的IND獲中國CDE及美國FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2560922523","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560922523?lang=zh_tw&edition=fundamental","pubTime":"2025-08-17 19:26","pubTimestamp":1755429967,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B 发布公告，集团自主研发的重组呼吸道合胞病毒疫苗(佐剂)的新药临床试验申请已经获得国家药品监督管理局药品审评中心批准。呼吸道合胞病毒作为一种高传染性RNA病毒，是导致婴儿、老年人和免疫功能不全者呼吸道感染的重要病原体之一。严重病例可危及生命。集团的重组呼吸道合胞病毒疫苗(佐剂)利用CHO细胞研制而成，可表达经修饰的pre-F蛋白。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330606.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4017","159646","LU1223083913.SGD","LU1223082519.USD","LU1223082196.USD","CDE","02627"],"gpt_icon":1},{"id":"2559465749","title":"科濟藥業發佈2025中期業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2559465749","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559465749?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 08:15","pubTimestamp":1755216900,"startTime":"0","endTime":"0","summary":"上海2025年8月15日 /美通社/ -- 科济药业，一家专注于开发创新CAR-T细胞疗法的生物制药公司，已发布2025中期业绩。截至2025年6月30日止六个月，科济药业的毛利约为人民币2,900万元。科济药业与华东医药已就在中国大陆地区商业化赛恺泽签订合作协议。于2025年上半年，赛恺泽完成认证及备案的医疗机构覆盖全国20多个省市，科济药业共计从华东医药获得111份有效订单。本次增资完成后，科济药业于优恺泽的股份将由100%稀释至92%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4751567_ZH51567_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4022","BK4195","BK4097","LU1223082196.USD","SLE","CAR","PFS","CDE","PCL","BK4230","BK4017","BK1161","02171","OS","BK4077","LU1223083913.SGD","BK1574","LU1223082519.USD","BK4211","BK1587","BK1585"],"gpt_icon":0},{"id":"2559595969","title":"上半年利潤或不少於2400萬元，樂普生物的“盈虧平衡術”奏效了","url":"https://stock-news.laohu8.com/highlight/detail?id=2559595969","media":"Ofweek维科网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559595969?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 16:30","pubTimestamp":1755160253,"startTime":"0","endTime":"0","summary":"近日，该公司宣布，根据对截至2025年6月30日止六个月的未经审核综合管理账目及董事会现时所得资料的初步评估，预计公司将取得利润不少于2400万元，上年同期则亏损约1.97亿元。从业绩预告来看，目前乐普生物已有部分BD款项入账。今年上半年，预计该产品打开了更大的市场空间，促进了乐普生物进入收获期。来源：医药研究社原文标题 : 上半年利润或不少于2400万元，乐普生物的“盈亏平衡术”奏效了","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081416313197473e19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081416313197473e19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4017","BK4231","TRAE","ADC","LU1223083913.SGD","LU1223082519.USD","BK4080","LU1223082196.USD","CDE"],"gpt_icon":0},{"id":"2559936618","title":"通化金馬：新藥在審評過程中出現暫停等情形正常狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=2559936618","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559936618?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 11:56","pubTimestamp":1755143817,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1223082196.USD","000766","BK0077","BK0239","LU1223083913.SGD","BK4017","BK0060","LU1223082519.USD","CDE"],"gpt_icon":0},{"id":"2559936877","title":"以諾康啓動上市輔導；綠谷971再註冊申請未獲批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2559936877","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559936877?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 08:34","pubTimestamp":1755131649,"startTime":"0","endTime":"0","summary":"根据新闻稿，Brinsupri是首个获FDA批准用于NCFB的治疗方案。资本市场高端医疗器械企业以诺康启动上市辅导8月12日，证监会网站披露，以诺康医疗科技（苏州）股份有限公司在江苏证监局上市辅导备案，辅导机构为华泰证券。截止本公告日，博灵脑机产品尚未正式上市，仅因与科研机构合作而销售少量产品。舆情预警绿谷971再注册申请未获批准2025年8月12日，国家药监局政务服务门户网站发布通知，绿谷制药的甘露特钠胶囊再注册申请未获批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250814083654a6e4c64a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250814083654a6e4c64a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EMA","LU1223082519.USD","BK4081","LU1223082196.USD","LU1223083913.SGD","BK4017","AD","CDE"],"gpt_icon":0},{"id":"2559602734","title":"榮昌生物：泰它西普治療原發性乾燥綜合徵Ⅲ期臨牀研究達到主要研究終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2559602734","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559602734?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 18:54","pubTimestamp":1755082497,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荣昌生物 发布公告，该公司自主研发的 BLyS/APRIL 双靶点融合蛋白创新药泰它西普用于治疗原发性干燥综合征的Ⅲ期临床研究，达到方案设计的临床试验主要研究终点。旨在评价泰它西普用于治疗原发性干燥综合征患者的有效性和安全性。研究表明，自身反应性的B细胞过度活化是干燥综合征发病的重要病理基础。泰它西普已经在中国完成治疗原发性干燥综合征的Ⅲ期临床研究，达到方案设计的临床试验主要研究终点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081318560497453674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081318560497453674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1223082196.USD","LU1223083913.SGD","LU1223082519.USD","BK4017","CDE"],"gpt_icon":0},{"id":"2559835269","title":"國內第2款！復宏漢霖和億勝生物\"貝伐珠單抗\"眼科製劑申報上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2559835269","media":"e公司","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559835269?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 13:57","pubTimestamp":1755064620,"startTime":"0","endTime":"0","summary":"8月13日，国家药品监督管理局药品审评中心官网显示，复宏汉霖和亿胜生物联合递交了贝伐珠单抗眼内注射液的上市申请。Insight数据库显示，这是第2个在国内报上市的贝伐珠单抗眼科制剂。据了解，亿胜生物已和复宏汉霖达成协议，在全球范围内共同开发HLX04-O用于治疗湿性年龄相关性黄斑变性等眼科疾病。今年6月，兆科眼科和东曜药业联合提交了贝伐珠单抗眼科制剂TAB014的上市申请，用于治疗wAMD，HLX04-O是第2款报产的此类药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508131358279744c184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508131358279744c184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4080","LU1223082519.USD","LU1223083913.SGD","IVT","CDE","LU1223082196.USD","BK4231","BK4017"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":181,"code":"91000000","status":"200"}]}}